Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.608M Est
Benzinga Newsdesk 5 days ago
NewsGuidance
Pulmonx (NASDAQ:LUNG) affirms FY2026 sales outlook from $90.000 million-$92.000 million to $90.000 million-$92.000 million vs $90.608 million estimate.
Pulmonx (NASDAQ:LUNG) affirms FY2026 sales outlook from $90.000 million-$92.000 million to $90.000 million-$92.000 million vs $90.608 million estimate.